Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) EBITDA Margin (QoQ) (2009 - 2026)

Analysis

Quest Diagnostics (DGX) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 130.00
Mar 31, 2026 3.00
Dec 31, 2025 5.00
Sep 30, 2025 -216.00
Jun 30, 2025 282.00
Mar 31, 2025 -73.00
Dec 31, 2024 51.00
Sep 30, 2024 -155.00
Jun 30, 2024 213.00
Mar 31, 2024 101.00
Dec 31, 2023 -323.00
Sep 30, 2023 2.00
Jun 30, 2023 180.00
Mar 31, 2023 730.00
Dec 31, 2022 -998.00
Sep 30, 2022 -5.00
Jun 30, 2022 -383.00
Mar 31, 2022 11.00
Dec 31, 2021 -397.00
Sep 30, 2021 260.00